[The Prognostic Value of Prognostic Nutritional Index Combined with D-dimer in Patients with Diffuse Large B-Cell Lymphoma]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Oct;31(5):1385-1393. doi: 10.19746/j.cnki.issn.1009-2137.2023.05.021.
[Article in Chinese]

Abstract

Objective: To explore the effects of prognostic nutritional index (PNI) combined with D-dimer on the prognosis of patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL).

Methods: The clinical data of 73 DLBCL patients at initial diagnosis were retrospectively evaluated, and the optimal cut-off point of PNI and D-dimer were determined by ROC curve. The overall survival (OS) rate and progression-free survival (PFS) rate in different subgroups were compared using Kaplan-Meier survival curves. Univariate and multivariate Cox regression analysis was performed to identify the factors associated with OS.

Results: Compared with the low PNI group (PNI<44.775), the high PNI group (PNI≥44.775) had better OS (P =0.022) and PFS (P =0.029), the 2-year OS rates of the two groups were 55.6% and 78.3% respectively (P =0.041). Compared with the high D-dimer group (D-dimer≥0.835), the low D-dimer group (D-dimer<0.835) had better OS (P <0.001) and PFS (P <0.001), the 2-year OS rates of the two groups were 51.4% and 86.8% respectively (P =0.001). Meanwhile, patients in the high PNI+ low D-dimer group had better OS (P =0.003) and PFS (P <0.001) than the other three groups, the 2-year OS rate was statistically different from the other three groups (P <0.05). The multivariate analysis revealed that NCCN-IPI (HR =2.083, 95%CI : 1.034-4.196, P =0.040), PNI (HR =0.267, 95%CI : 0.076-0.940, P =0.040) and PNI+D-dimer (HR =9.082, 95%CI : 1.329-62.079, P =0.024) were the independent risk factors affecting OS in patients with DLBCL. Subgroup analysis showed that PNI, D-dimer, and PNI combined with D-dimer could improve the prognostic stratification in low and low-intermediate risk DLBCL patients.

Conclusion: High PNI, low D-dimer and combination of high PNI and low D-dimer at initial diagnosis suggest a better prognosis in DLBCL patients.

题目: 预后营养指数联合D-二聚体对弥漫大B细胞淋巴瘤患者预后的评估价值.

目的: 探究预后营养指数(PNI)联合D-二聚体(D-dimer)对初诊弥漫大B细胞淋巴瘤(DLBCL)患者预后的影响。.

方法: 回顾性分析73例DLBCL患者初诊时的临床资料,通过ROC曲线确定PNI和D-dimer的最佳截断值;采用Kaplan-Meier生存曲线比较不同分组患者的总生存(OS)率和无进展生存(PFS)率;采用Cox回归模型进行单变量和多变量分析,确定与OS相关的因素。.

结果: 与低PNI组(PNI<44.775)相比,高PNI组(PNI≥44.775)有更好的OS(P =0.022)和PFS(P =0.029),两组2年OS率分别为55.6%和78.3%(P =0.041);与高D-dimer组(D-dimer≥0.835)相比,低D-dimer组(D-dimer<0.835)具有更好的OS(P <0.001)和PFS(P <0.001),两组2年OS率分别为51.4%和 86.8%(P =0.001);同时,高PNI+低D-dimer组患者较其他3组具有更好的OS(P =0.003)和PFS(P <0.001),2年OS 率具有统计学差异(P <0.05)。多因素分析结果显示,NCCN-IPI(HR =2.083,95% CI :1.034-4.196,P =0.040)、PNI(HR = 0.267,95% CI :0.076-0.940,P =0.040)、PNI+D-dimer(HR =9.082,95% CI :1.329-62.079,P =0.024)是影响DLBCL患 者OS的独立危险因素。亚组分析结果发现,PNI、D-dimer、PNI联合D-dimer能够改善低危、低中危DLBCL患者的预 后分层。.

结论: 初诊时高PNI、低D-dimer及高PNI+低D-dimer的DLBCL患者具有更好的预后。.

Keywords: D-dimer; diffuse large B-cell lymphoma; prognosis; prognostic nutritional index.

Publication types

  • English Abstract

MeSH terms

  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / diagnosis
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • Nutrition Assessment*
  • Prognosis
  • Retrospective Studies

Substances

  • fibrin fragment D